Venous thromboembolism in pediatric patients with acute lymphoblastic leukemia under chemotherapy treatment. Risk factors and usefulness of thromboprophylaxis. Results of LAL-SEHOP-PETHEMA-2013

Autor: Anna Ruiz‐Llobet, Susanna Gassiot, Edurne Sarrate, Josune Zubicaray, José Luis Dapena, Susana Rives, Julián Sevilla, Ángela Menárguez López, Melissa Panesso Romero, Catalina Montoya, José Manuel Vagace, José Ramón Molina Hurtado, Marina García‐Morín, Miriam García Abós, María Carmen Mendoza Sánchez, Francisco Lendínez, Pilar Palomo Moraleda, María Tallón, Berta González, Emilia Urrutia, José Vicente Serna, Irene Peláez Pleguezuelos, Marta Martínez Merino, Eduardo Ramos Elbal, Elena Orellana, Helga Benítez Muñoz, Rubén Berrueco

Publikováno v: JOURNAL OF THROMBOSIS AND HAEMOSTASIS
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu

Introduction: Symptomatic venous thromboembolism (VTE) is diagnosed in 3%14% of patients during pediatric acute lymphoblastic leukemia (ALL) therapy. There are well-known risk factors, but the role of others as inherited thrombophilia is still contro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54b81ef734891d03fbf2180b378d0c8e
https://pubmed.ncbi.nlm.nih.gov/35289066